Anzeige
Mehr »
Login
Dienstag, 28.01.2025 Börsentäglich über 12.000 News von 683 internationalen Medien
Energiekrise als Chance: Mit dieser Aktie starten Sie ins Börsenjahr 2025 durch!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
302 Leser
Artikel bewerten:
(2)

Pudu Robotics Unveils PUDU D9: A Full-Sized Humanoid Robot Driving Commercially Viable Embodied Intelligence

Finanznachrichten News

SHENZHEN, China, Dec. 19, 2024 /PRNewswire/ -- Pudu Robotics, a global leader in service robotics sector, has launched its first Full-sized Bipedal Humanoid Robot, the PUDU D9. Developed by the Pudu X-Lab, this innovative robot follows the releases of the semi-humanoid robot PUDU D7 and the dexterous hand PUDU DH11, marking the third product from the team this year.

Standing at 170 cm tall and weighing 65 kg, the PUDU D9 features 42 degrees of freedom across its joints, with a maximum joint torque of 352 Nm. It is equipped with the previously released PUDU DH11 dexterous hand, enabling human-like bipedal walking and dual-hand operational capabilities. In the demonstration video, PUDU D9 showcased its impressive mobility, including upright walking, obstacle navigation, slope climbing, and performing ground cleaning tasks using the PUDU SH1, another product in the PUDU's lineup.

Aiming for commercially viable embodied intelligence, the PUDU D9 will soon be available for pre-sale, with inquiries currently being accepted through Pudu Robotics' official website.

The PUDU D9 is designed with a human-centric philosophy, embodying the principle of "Born to Serve." As a fully anthropomorphic robot, its design closely mirrors human capabilities while striving to provide practical assistance across a diverse range of applications.

Key Capabilities of PUDU D9:

  • Dynamic Mobility: The PUDU D9's bipedal structure enables it to walk at speeds comparable to that of adults, reaching up to 2 m/s on flat surfaces. It can easily navigate stairs, slopes, and other challenging urban terrains. Utilizing advanced algorithms, the robot achieves lightweight gait control, minimizing noise during operation in human environments. Its cutting-edge visual semantic navigation system is equipped with high-accuracy sensors that allow for real-time 3D semantic mapping, providing the D9 with a comprehensive understanding of its surroundings. This capability ensures accurate self-positioning and autonomous route planning.
  • Precision Manipulation: Equipped with two 7-degree-of-freedom robotic arms, the PUDU D9 boasts a payload capacity exceeding 20 kg. When paired with the PUDU DH11 dexterous hand, it excels in executing delicate tasks across a wide range of applications. Leveraging years of research and development, along with proprietary reinforcement learning algorithms, the PUDU D9 can rapidly learn from extensive datasets, effectively executing end-to-end task planning to meet various operational demands.
  • Seamless Natural Interaction: The PUDU D9 features a range of high-precision visual, tactile, force, and auditory sensors that empower it to collect multimodal information from its environment. Through a sophisticated processing framework that integrates advanced AI models, the D9 achieves human-level multimodal natural interactions, significantly enhancing the quality and responsiveness of the services it provides.

With the introduction of the PUDU D9, Pudu Robotics has established a comprehensive product lineup that includes specialized, semi-humanoid, and humanoid robots. Building on this strong foundation, the company aims to achieve commercially viable embodied intelligence and will actively explore innovations in the core capabilities of robot AI, mobility, and operational technology.

As a global leader in commercial service robotics, Pudu Robotics remains committed to prioritizing user needs by leveraging its strong foundation in technology, product development, supply chain management, and market channels. Felix Zhang, founder and CEO of Pudu Robotics, emphasized," Customer centricity has always been at the core of PUDU's values. Moving forward, we will continue to explore technology driven by customer needs and pain points. Our extensive experience in the commercial service sector will help accelerate the maturity of semi-humanoid and humanoid robots, allowing more people to enjoy the convenience of robotic services."

About Pudu Robotics

Pudu Robotics, a global leader in the service robotics sector, is dedicated to enhancing human productivity and living standards through innovative robot technology. With a focus on R&D, manufacturing, and sales of service robots, Pudu Robotics holds over a thousand authorized patents worldwide, encompassing a wide range of core technologies. The company's robots have been widely adopted in various industries, including dining, retail, hospitality, healthcare, entertainment, education and manufacturing. To date, Pudu Robotics has successfully shipped over 80,000 units to a variety of markets, with a presence in more than 60 countries and regions worldwide. For more information on business developments and updates, follow PUDU on LinkedIn, Facebook, YouTube, Twitter and Instagram.

PUDU LOGO

Video - https://mma.prnewswire.com/media/2585172/PUDU_D9_Final_EN.mp4
Logo - https://mma.prnewswire.com/media/2492578/Pudu_Robotics_Logo.jpg

Cision View original content:https://www.prnewswire.co.uk/news-releases/pudu-robotics-unveils-pudu-d9-a-full-sized-humanoid-robot-driving-commercially-viable-embodied-intelligence-302336126.html

© 2024 PR Newswire
Gewinner im Megamarkt
Biotechnologie ist eine der bedeutendsten Zukunftstechnologien unserer Zeit. Zahlreiche Biotechnologie- und Pharmakonzerne haben sich unter anderem dem Kampf gegen Tumorerkrankungen verschrieben. Der weltweite Markt für Krebsmedikamente verzeichnet ein stetiges Wachstum. Für das Jahr 2025 wird ein Umsatz von etwa 190,3 Milliarden Euro prognostiziert, mit einer erwarteten jährlichen Wachstumsrate von 6,42% bis 2029, was zu einem geschätzten Marktvolumen von 244,1 Milliarden Euro führen würde.

Wir haben 3 aussichtsreiche Biotechnologieaktien mit Schwerpunkt Erforschung und Entwicklung von Wirkstoffen gegen Tumorerkrankungen ausfindig gemacht, die in den kommenden Monaten und Jahren erhebliches Aufwärtspotenzial versprechen und Vervielfachungspotenzial besitzen.

Fordern Sie jetzt unseren neuen kostenlosen Spezialreport an und erfahren Sie, welche 3 Biotech-Aktien durchstarten und zu Ihrem Börsenerfolg in 2025 beitragen könnten!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.